Fernando Aguirre — investor profile photo

Fernando Aguirre

CEO at HAWK Biosystems

📍 Greater Bilbao Metropolitan Area, Spain🔄 Updated November 2026💼 4 investments📅 12 years investing🗓 Last invested Jan 2016
Operator-angel🌍 Spain
4
Total investments
2
Early stage
0
Mid stage
0
Late stage
12y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jan 2016
Datos únicos y de alto valor basados en procesos de Big Data e IA para apoyar a empresas y organismos públicos en la gestión territorial y turística: Oferta turística, competitividad de destino e Indicadores avanzados.
Member of the Board
Feb 2015
IRISBOND creates a new way for humans to communicate through eye-tracking technology. Irisbond’s advanced software algorithms interpret your eye gaze in order to provide natural, intuitive and hands-free access to information and control over a screen. Learn more: https://www.irisbond.com/ Contact us in: info@irisbond.com
Experience · 9 entries
All (9)
Investments (4)
Founder (3)
Board (4)
2018
Board Member, Managing Director
Jun 2018
HAWK Biosystems (formerly FASTBASE Solutions) are a biosystems company founded in Bizkaia by Spanish and British scientists from the Francis Crick Institute in London. We have developed a technology that allows for the discovery and quantification of novel biomarkers within any disease state. Specifically, we can determine with high precision which patients will respond to immune-therapy and can stratify patients for treatment using our assay, QF-Pro®. We offer the QF-Pro® service which can be used to discover and quantify biomarkers in FFPE tissue and cell samples and we also offer a custom assay creation service.
mid stageBiotechnology
2016
Board Member
Jan 2016
Datos únicos y de alto valor basados en procesos de Big Data e IA para apoyar a empresas y organismos públicos en la gestión territorial y turística: Oferta turística, competitividad de destino e Indicadores avanzados.
2015
Co-founder
Oct 2015
Prospero Biosciences has developed an ion detector that effectively increases the characterization and identification capabilities that is 30 times better than what is currently available. With our patented detection system, our researchers can extend the dynamic range limits with unmatched resolution and sensitivity in the field of mass spectrometry. Our detection system will assist scientists and clinicians make advancements for applications in virus detection, proteomics, pharmaceuticals, and diagnostics. We provide a high mass molecule detector for the mass spectrometry market, more specifically for the MALDI-TOF and Q-TOF segment. The technology provides 15 times better resolution compared to the competitor, which is crucial for accurate identification. The company is currently developing a universal detector.
Member of the Board
Feb 2015
IRISBOND creates a new way for humans to communicate through eye-tracking technology. Irisbond’s advanced software algorithms interpret your eye gaze in order to provide natural, intuitive and hands-free access to information and control over a screen. Learn more: https://www.irisbond.com/ Contact us in: info@irisbond.com
Nito, Inc.
Member of the Board
Feb 2015
Show all 9 entries ↓
Investment activity
2014–2016 · 4 investments
201412015220161
Recent (last 2 years)Earlier
Investor lists
Lists that match Fernando's portfolio